Neurotensin serum levels and skin gene expression are increased in atopic dermatitis

British Journal of Dermatology

Volumn 169, Issue 3, 2013, Pages 695-699

  Vasiadi, M ^a,b,c   Mondolfi, A P ^d,g,h   Alysandratos, K D ^a,i   Therianou, A ^b   Katsarou Katsari, A ^b   Petrakopoulou, T ^e   Theoharidis, A ^f   Miniati, A ^a,j   Theoharides, T C ^a,b,c,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c TUFTS UNIVERSITY   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e Agios Savas Anticancer Hospital   (Greece)

^f Ano Toumba Polyclinic IKA   (Greece)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF TEXAS AT DALLAS   (United States)

ⁱ LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^j INSTITUTO DE BIOMEDICINA   (Venezuela)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; NEUROTENSIN; NEUROTENSIN RECEPTOR; VASCULOTROPIN;

ADULT; ARTICLE; ATOPIC DERMATITIS; CHRONIC URTICARIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; URTICARIA PIGMENTOSA;

ADULT; DERMATITIS, ATOPIC; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAST CELLS; NEUROTENSIN; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NEUROTENSIN; SKIN; URTICARIA; URTICARIA PIGMENTOSA;

EID: 84883397660     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12413     Document Type: Article

References (16)

1. Carraway R, Leeman SE,. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 1973; 248: 6854-61.
2. Cochrane DE, Carraway RE, Harrington K, et al,. HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1. Inflamm Res 2011; 60: 1139-51.
3. Donelan J, Boucher W, Papadopoulou N, et al,. Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci USA 2006; 103: 7759-64.
4. Galli SJ, Grimbaldeston M, Tsai M,. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008; 8: 478-86.
5. Theoharides TC, Alysandratos KD, Angelidou A, et al,. Mast cells and inflammation. Biochim Biophys Acta 2010; 1822: 21-33.
6. Metz M, Maurer M,. Mast cells-key effector cells in immune responses. Trends Immunol 2007; 28: 234-41.
7. Bieber T,. Atopic dermatitis. N Engl J Med 2008; 358: 1483-94.
8. Jarvikallio A, Harvima IT, Naukkarinen A,. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003; 295: 2-7.
9. Pincelli C, Fantini F, Massimi P, et al,. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 1990; 122: 745-50.
10. Vasiadi M, Therianou A, Alysandratos KD, et al,. Serum neurotensin (NT) is increased in psoriasis and NT induces VEGF release from human mast cells. Br J Dermatol 2012; 166: 1349-52.
11. Angelidou A, Francis K, Vasiadi M, et al,. Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation 2010; 7: 48.
12. Yaghmaie P, Koudelka CW, Simpson EL,. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol 2013; 131: 428-33.
13. Angelidou A, Asadi S, Alysandratos KD, et al,. Perinatal stress, brain inflammation and risk of autism-review and proposal. BMC Pediatr 2012; 12: 89.
14. Alysandratos KD, Asadi S, Angelidou A, et al,. Neurotensin and CRH interactions augment human mast cell activation. PLoS ONE 2012; 7: e48934.
15. Vasiadi M, Therianou A, Sideri K, et al,. Increased serum CRH levels with decreased skin CRH-R1 gene expression in psoriasis and atopic dermatitis. J Allergy Clin Immunol 2012; 129: 1410-13.
16. Paus R, Theoharides TC, Arck PC,. Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 2006; 27: 32-9.